Another logistical issue with injectable GLP-1 drugs is that they require refrigeration throughout the supply chain
GLP-1 receptor agonists GLP-1 receptor monoagonists According to their pharmacodynamics and pharmacokinetic properties, the GLP-1RAs are categorized as either short-acting or long-acting agents
Still, Skovronsky said, "I think we're making history here, both on the high end with the high dose and on the low dose for what we can offer patients." "For some patients, 30% weight loss may be more than what they're seeking," Skovronsky later added
Sustainability Concerns : The requirement for potentially lifelong therapy, combined with rapid weight regain upon discontinuation, raises questions about long-term sustainability and practical implementation
The burden of CKD resulting from T2D, quantified with disability and mortality risk measures, has increased since 1990, mostly due to population expansion and ageing [2]
MOTS-c also activates AMPK in muscle and improves mitochondrial function, which supports training capacity when calories are low
